Rebound
- Manufacturer
- Activon | Longwood Scientific, LLC
- Effective date
- 2021-12-29
- Label type
- OTC ANIMAL DRUG LABEL
- Version
- 8
- Source
- legacy-cache
- Hydrated at
- 2026-08-01 22:20:10
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
DOSAGE & ADMINISTRATION SECTION
For Best Results
Add tablets to any potable water and allow to fully dissolve before use.
Rebound solution may be used for up to 7-10 days after mixing.
Use a clean container to store and mix solutions.
Keep tablet container dry and tightly closed between uses.
DILUTION RATE
Recommended Strength:
One tablet = One gallon
Convenient two quart mixing scoops available.
To order call 1-800-841-0410
PRECAUTIONS SECTION
PRECAUTIONS:
PRECAUTION: Keep out of reach of children.
Do not take internally.
Not for human consumption.
Do not mix with bleach, acids, ammonia, or non-ionic detergents.
EYE CONTACT: Flush eyes with clean water.
Seek medical advice.
IF SWALLOWED: Drink large quantities of water, do not induce vomiting.
Seek medical advice immediately.
DO NOT INHALE VAPORS from closed containers of stored solutions of Rebound.
Open in well ventilated areas.
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
Rebound
Ready to use sanitizing
teat dip and spray
Helps kill mastitus-causing organisms
Concentrated effervescent tablets
ACTIVE INGREDIENT:
Sodium Dichloro-s-Triazinetrione.............50%
INERT INGREDIENTS:...........................50%
Available Chlorine......30% Total........100%
Teat Dip
NDC 14925-202-02
Makes 1,000 gallons of teat dip or spray
1,000 TABLETS (17.68g/tablet)
Net Wt. 38.98 lbs. (17.68 kg)
Manufactured for
Activon
123 Commercial Drive, Beaver Dam, WI 53916
wwww.activon.com 1-800-841-0410
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| TROCLOSENE SODIUM | ACTIVE INGREDIENT | 07M9U9U0LK | 1 | |
| CHLORINE | ACTIVE MOIETY | 4R7X1O2820 | 1 | |
| ADIPIC ACID | INACTIVE INGREDIENT | 76A0JE0FKJ | 1 | |
| SODIUM BICARBONATE | INACTIVE INGREDIENT | 8MDF5V39QO | 1 | |
| SODIUM CARBONATE | INACTIVE INGREDIENT | 45P3261C7T | 1 |
Products#
Every source-derived product name is available through these pages.
- Rebound
- TROCLOSENE SODIUM
- CHLORINE
- ADIPIC ACID
- SODIUM BICARBONATE
- SODIUM CARBONATE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 14925-202 | 14925-202-02 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| TROCLOSENE SODIUM | 07M9U9U0LK | ACTIB |
| ADIPIC ACID | 76A0JE0FKJ | IACT |
| SODIUM BICARBONATE | 8MDF5V39QO | IACT |
| SODIUM CARBONATE | 45P3261C7T | IACT |
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| SODIUM BICARBONATE | SODIUM BICARBONATE | 8MDF5V39QO | CAPSULE / ORAL | 320 mg | ||
| SODIUM BICARBONATE | SODIUM BICARBONATE | 8MDF5V39QO | INJECTION, POWDER, FOR SUSPENSION / INTRAVENOUS | 160 mg | ||
| SODIUM BICARBONATE | SODIUM BICARBONATE | 8MDF5V39QO | TABLET / BUCCAL | 42 mg | ||
| SODIUM CARBONATE | SODIUM CARBONATE | 45P3261C7T | TABLET / ORAL | 100 mg | ||
| ADIPIC ACID | ADIPIC ACID | 76A0JE0FKJ | INJECTION / INTRAMUSCULAR | 1 %w/v | ||
| SODIUM BICARBONATE | SODIUM BICARBONATE | 8MDF5V39QO | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAMUSCULAR | ADJ PH | ||
| SODIUM CARBONATE | SODIUM CARBONATE | 45P3261C7T | INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR | 630 mg | ||
| SODIUM BICARBONATE | SODIUM BICARBONATE | 8MDF5V39QO | LOZENGE / ORAL | 100 mg | ||
| SODIUM CARBONATE | SODIUM CARBONATE | 45P3261C7T | INJECTION / INTRAVENOUS | 241 mg | ||
| SODIUM BICARBONATE | SODIUM BICARBONATE | 8MDF5V39QO | GUM, CHEWING / BUCCAL | 240 mg | ||
| SODIUM BICARBONATE | SODIUM BICARBONATE | 8MDF5V39QO | INSERT / VAGINAL | 129 mg | ||
| SODIUM CARBONATE | SODIUM CARBONATE | 45P3261C7T | TABLET, EXTENDED RELEASE / ORAL | 80 mg | ||
| SODIUM CARBONATE | SODIUM CARBONATE | 45P3261C7T | INJECTION, SOLUTION / INTRAVENOUS | ADJ PH | ||
| SODIUM CARBONATE | SODIUM CARBONATE | 45P3261C7T | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | 1248 mg | ||
| SODIUM CARBONATE | SODIUM CARBONATE | 45P3261C7T | GRANULE, FOR SUSPENSION / ORAL | 39 mg | ||
| SODIUM BICARBONATE | SODIUM BICARBONATE | 8MDF5V39QO | INJECTION / INTRAVITREAL | 0.18 %w/v | ||
| SODIUM BICARBONATE | SODIUM BICARBONATE | 8MDF5V39QO | INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR | 1000 mg | ||
| SODIUM BICARBONATE | SODIUM BICARBONATE | 8MDF5V39QO | TABLET / SUBLINGUAL | 6 mg | ||
| SODIUM BICARBONATE | SODIUM BICARBONATE | 8MDF5V39QO | TABLET, COATED / ORAL | 10.6 mg | ||
| SODIUM BICARBONATE | SODIUM BICARBONATE | 8MDF5V39QO | INJECTION / INTRAMUSCULAR | 175 mg | ||
| SODIUM CARBONATE | SODIUM CARBONATE | 45P3261C7T | INJECTION, SOLUTION / INTRAVASCULAR | ADJ PH | ||
| SODIUM CARBONATE | SODIUM CARBONATE | 45P3261C7T | TABLET, FILM COATED / ORAL | 30 mg | ||
| SODIUM BICARBONATE | SODIUM BICARBONATE | 8MDF5V39QO | TABLET, EFFERVESCENT / ORAL | 57600 mg | ||
| SODIUM BICARBONATE | SODIUM BICARBONATE | 8MDF5V39QO | TABLET / ORAL | 1300 mg | ||
| SODIUM CARBONATE | SODIUM CARBONATE | 45P3261C7T | TABLET, EFFERVESCENT / ORAL | 430 mg | ||
| SODIUM CARBONATE | SODIUM CARBONATE | 45P3261C7T | INJECTION / INTRAVASCULAR | ADJ PH | ||
| SODIUM CARBONATE | SODIUM CARBONATE | 45P3261C7T | INJECTION / INFILTRATION | ADJ PH | ||
| SODIUM BICARBONATE | SODIUM BICARBONATE | 8MDF5V39QO | SOLUTION / ORAL | ADJ PH | ||
| SODIUM CARBONATE | SODIUM CARBONATE | 45P3261C7T | SUSPENSION / ORAL | 48 mg | ||
| SODIUM BICARBONATE | SODIUM BICARBONATE | 8MDF5V39QO | CAPSULE, DELAYED RELEASE PELLETS / ORAL | 4 mg | ||
| SODIUM BICARBONATE | SODIUM BICARBONATE | 8MDF5V39QO | TABLET, DELAYED RELEASE / ORAL | 30 mg | ||
| SODIUM CARBONATE | SODIUM CARBONATE | 45P3261C7T | INJECTION, SOLUTION / INTRA-ARTERIAL | ADJ PH | ||
| SODIUM CARBONATE | SODIUM CARBONATE | 45P3261C7T | INJECTION / SUBCUTANEOUS | ADJ PH | ||
| ADIPIC ACID | ADIPIC ACID | 76A0JE0FKJ | INSERT / VAGINAL | 171 mg | ||
| SODIUM CARBONATE | SODIUM CARBONATE | 45P3261C7T | TABLET, DELAYED RELEASE / ORAL | 90 mg | ||
| SODIUM CARBONATE | SODIUM CARBONATE | 45P3261C7T | GUM, CHEWING / BUCCAL | 720 mg | ||
| SODIUM BICARBONATE | SODIUM BICARBONATE | 8MDF5V39QO | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 3059 mg | ||
| SODIUM BICARBONATE | SODIUM BICARBONATE | 8MDF5V39QO | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 6 mg | ||
| SODIUM BICARBONATE | SODIUM BICARBONATE | 8MDF5V39QO | INJECTION, SOLUTION / INTRAVENOUS | 52 mg | ||
| SODIUM BICARBONATE | SODIUM BICARBONATE | 8MDF5V39QO | POWDER, FOR SOLUTION / ORAL | 1250 mg/100ml | ||
| SODIUM CARBONATE | SODIUM CARBONATE | 45P3261C7T | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 1247 mg | ||
| SODIUM CARBONATE | SODIUM CARBONATE | 45P3261C7T | TABLET / BUCCAL | 20 mg | ||
| SODIUM BICARBONATE | SODIUM BICARBONATE | 8MDF5V39QO | TABLET, CHEWABLE / ORAL | 140 mg | ||
| SODIUM BICARBONATE | SODIUM BICARBONATE | 8MDF5V39QO | GUM, CHEWING / ORAL | 360 mg | ||
| SODIUM CARBONATE | SODIUM CARBONATE | 45P3261C7T | LOZENGE / ORAL | 500 mg | ||
| SODIUM CARBONATE | SODIUM CARBONATE | 45P3261C7T | CAPSULE, EXTENDED RELEASE / ORAL | 6 mg | ||
| SODIUM BICARBONATE | SODIUM BICARBONATE | 8MDF5V39QO | GRANULE, EFFERVESCENT / ORAL | 267 mg | ||
| SODIUM BICARBONATE | SODIUM BICARBONATE | 8MDF5V39QO | INJECTION, POWDER, FOR SOLUTION / INTRAPERITONEAL | ADJ PH | ||
| SODIUM BICARBONATE | SODIUM BICARBONATE | 8MDF5V39QO | TABLET, FILM COATED / ORAL | 86 mg | ||
| SODIUM BICARBONATE | SODIUM BICARBONATE | 8MDF5V39QO | TABLET, ORALLY DISINTEGRATING / ORAL | 107 mg | ||
| SODIUM BICARBONATE | SODIUM BICARBONATE | 8MDF5V39QO | INJECTION / INTRATHECAL | 0.05 mg | ||
| SODIUM CARBONATE | SODIUM CARBONATE | 45P3261C7T | INJECTION / INTRAMUSCULAR | 32.4 mg | ||
| SODIUM BICARBONATE | SODIUM BICARBONATE | 8MDF5V39QO | SOLUTION / RESPIRATORY (INHALATION) | 2 %w/w | ||
| SODIUM CARBONATE | SODIUM CARBONATE | 45P3261C7T | GUM, CHEWING / ORAL | 240 mg | ||
| SODIUM CARBONATE | SODIUM CARBONATE | 45P3261C7T | SOAP / TOPICAL | 0.5 %w/w | ||
| SODIUM BICARBONATE | SODIUM BICARBONATE | 8MDF5V39QO | TABLET, EXTENDED RELEASE / ORAL | 81 mg | ||
| SODIUM BICARBONATE | SODIUM BICARBONATE | 8MDF5V39QO | FILM, SOLUBLE / ORAL | 2 mg | ||
| SODIUM CARBONATE | SODIUM CARBONATE | 45P3261C7T | TROCHE / ORAL | 375 mg | ||
| SODIUM CARBONATE | SODIUM CARBONATE | 45P3261C7T | SOLUTION / OPHTHALMIC | 0.01 %w/v | ||
| SODIUM CARBONATE | SODIUM CARBONATE | 45P3261C7T | CAPSULE, DELAYED RELEASE / ORAL | 90 mg |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
